Physician profile
Bill E Hukill
NPI 1689776320
$3,160.06
in general payments reported to CMS, 2019-2025
31 companies · $556 in 2025
The $556 reported for 2025 was more than what 75% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $504 · 2020: $237 · 2021: $431 · 2022: $330 · 2023: $498 · 2024: $605 · 2025: $556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,658.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $481.89 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $444.24 | 2019-2025 | Repatha, Otezla, Repatha |
| Novartis Pharmaceuticals Corporation | $333.64 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $260.99 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $257.65 | 2019-2025 | Jardiance, Stiolto Respimat, Ofev |
| Exact Sciences Corporation | $162.98 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $139.49 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $132.14 | 2019 | |
| Abbvie INC. | $131.78 | 2021-2025 | |
| Lilly USA, LLC | $115.19 | 2020-2025 | Zepbound, Mounjaro, Jardiance |
| Glaxosmithkline, LLC. | $114.38 | 2020-2025 | Trelegy Ellipta, Arexvy |
| Regeneron Healthcare Solutions, INC. | $77.86 | 2023-2025 | Evkeeza |
| Astellas Pharma US INC | $65.99 | 2019-2024 | Veozah |
| Amarin Pharma, INC. | $56.82 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $52.01 | 2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $43.51 | 2021-2023 | Strensiq |
| Abbott Laboratories | $34.54 | 2024-2025 | Freestyle Libre 3 |
| Radius Health, INC. | $31.83 | 2019-2025 | Tymlos |
| Biohaven Pharmaceutical Holding Company LTD. | $25.83 | 2022 | |
| Eisai INC. | $19.77 | 2024 | |
| Alvogen INC | $19.36 | 2024 | Teriparatide |
| Phathom Pharmaceuticals, INC. | $18.75 | 2024 | Voquezna |
| Cashflow Solutions, LLC | $18.60 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Mylan Specialty L.P. | $18.21 | 2021 | |
| Allergan, INC. | $17.74 | 2020 | |
| Jazz Pharmaceuticals INC. | $15.15 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $14.94 | 2025 | Eliquis |
| Ibsa Pharma INC. | $14.27 | 2023 | Licart, Tirosint |
| Sunovion Pharmaceuticals INC. | $13.63 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.57 | 2020 | |
| Dexcom, INC. | $13.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bill Hukill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.